This paper was discharged for "In-vitro biological experiment for new pharmacology compounds at high-altitude-area (HAA), Taif, KSA". The mean of antimicrobial effects on Staphylococcous aureus (SA), as antibacterial effect were at (1, 3, 5 and 7hr). The mean antimicrobial were in descendant order by antibacterial as followed (K1, K2, k3, K4, K5 and K6) were 100% at 7hr. Nevertheless, (K3 and K6) were 100% since 5hr. The newly synthesized compounds inhibitory concentration presented high important activity against SA. The mean of antimicrobial effects on Escherichia coli (EC), as antibacterial more effective (K1, K2, K3 and K5) were 100% at 7hr, then (K4 and K5) were (95 and 90%). The mean antibacterial during the exposure hrs and the averages were in descendent command by antibacterial fraction. The inhibitory concentration presented by using pharmacology compounds high important activity against EC. The mean of antimicrobial effects on Candida albicans (CA), the effect as antifungal were included (1, 3, 5 and 7hr). The means were in descendant order by the fraction of antifungal, the more effective were (K2, K3 and K6) were 100% at 7hr, and then (K1, K4 and K5) were (90, 95 and 85%). The effective was clear with pharmacology compounds. This present applied work concluded pharmacology compounds had effective more powerful than antimicrobial agents did. As well, it could be institution of antimicrobial agents for "Health-program" (HP) at HAA. Using new pharmacology compounds instead of chemical antimicrobial substances to protect human body from side effects and could improve HP at HAA.